Abstract
Background
Selenium (Se) is an essential micronutrient for animals and humans used in the prevention or treatment of cancer. Selol is a mixture of selenitetriglycerides, containing Se(IV). It does not exhibit mutagenic activity and is less toxic than inorganic sodium selenite containing Se(IV). The antioxidant properties of the Selol were demonstrated using the blood of healthy animals. The aim of the study was to evaluate Selol as a Se supplement by determining the effect of its administration on the Se level and the antioxidant status in the tissues.
Methods
We examined the effect of long-term (28-day) Selol 5% supplementation on the activity of antioxidant enzymes, including the main selenoenzymes in healthy mice organs, such as liver, brain, lungs, and testis. Enzyme activities of the tissue homogenates and the concentration of malondialdehyde (MDA) as a biomarker of oxidative stress were measured using spectrophotometric methods. The selenium concentrations in the tissues were determined by inductively coupled plasma mass spectrometer (ICP-MS) as well.
Results
A significant increase in glutathione peroxidase, thioredoxin reductase, and glutathione S-transferase activity as well as the MDA concentration was observed in most of the studied tissues during the Selol 5% supplementation.
Conclusions
Long-term supplementation with the new Se(IV) compound — Selol 5% significantly affects the activity of antioxidant enzymes and the redox state in healthy mice organs. In the healthy population Selol 5% seems to be a promising new antioxidant compound.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Rayman M.P.. Selenium and human health. Lancet 2012;379(9822):1256–68.
Dominiak A, Wilkaniec A, Wroczynski P, Adamczyk A. Selenium in the therapy of neurological diseases. Where is it going? Curr Neuropharmacol 2016;14(3):282–99.
Gromer S, Urig S, Becker K. The thioredoxin system-from science to clinic. Med Res Rev 2004;24(1):40–89.
Brigelius-Flohe R. Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 1999;27(9–10):951–65.
Lanfear J, Fleming J, Wu L, Webster G, Harrison PR. The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 1994;15(7):1387–92.
Drake EN. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med Hypotheses 2006;67(2):318–22.
Soriano-Garcia M. Organoselenium compounds as potential therapeutic and chemopreventive agents: a review. Curr Med Chem 2004;11(12):1657–69.
Jastrzebski Z, Czyzewska-Szafran H, Fijatek Z, Suchocki P, Fitak BA. Toxicity studies of a new selenium compound, Selol, in rats. Drugs Exp Clin Res 1995;21(6):217–20.
Rahden-Staron I, Suchocki P, Czeczot H. Evaluation of mutagenic activity of the organo-selenium compound Selol by use of the Salmonella typhimurium mutagenicity assay. Mutat Res 2010;699(1–2):44–6.
Wendel A. Glutathione peroxidase. Methods Enzymol 1981;77:325–33.
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70(1):158–69.
Sochacka M, Giebultowicz J, Remiszewska M, Suchocki P, Wroczynski P. Effects of Selol 5% supplementation on the activity or concentration of antioxidants and malondialdehyde level in the blood of healthy mice. Pharmacol Rep 2014;66(2):301–10.
Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249(25):7130–9.
Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000;346:1–8.
Hill KE, McCollum GW, Boeglin ME, Burk RF. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun 1997;234(2):293–5.
Gromer S, Johansson L, Bauer H, Arscott LD, Rauch S, Ballou DP, et al. Active sites of thioredoxin reductases: why selenoproteins? Proc Natl Acad Sci USA 2003;100(22):12618–23.
Nixon DE, Moyer TP, Burritt MF. The determination of selenium in serum and urine by inductively coupled plasma mass spectrometry: comparison with Zeeman graphite furnace atomic absorption spectrometry. Spectrochim Acta B 1999;54(6):931–42.
Brenneisen P, Steinbrenner H, Sies H. Selenium, oxidative stress, and health aspects. Mol Aspects Med 2005;26(4–5):256–67.
Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 1999;20(9):1657–66.
Dominiak A, Wilkaniec A, Jesko H, Czapski GA, Lenkiewicz AM, Kurek E, et al. Selol, an organic selenium donor, prevents lipopolysaccharide-induced oxidative stress and inflammatory reaction in the rat brain. Neurochem Int 2017;108:66–7.
Corcoran NM, Najdovska M, Costello AJ. Inorganic selenium retards progression of experimental hormone refractory prostate cancer. J Urol 2004;171(2, Part 1):907–10.
Crespo AM, Neve J, Pinto RE. Plasma and liver selenium levels in the rat during supplementation with 0.5, 2, 6, and 15 ppm selenium in drinking water. Biol Trace Elem Res 1993;38(2):139–47.
Thompson KG, Fraser AJ, Harrop BM, Kirk JA, Bullians J, Cordes DO. Glutathione peroxidase activity and selenium concentration in bovine blood and liver as indicators of dietary selenium intake. N Z Vet J 1981;29(1–2):3–6.
Weiss SL, Sunde RA. Selenium regulation of classical glutathione peroxidase expression requires the 3′ untranslated region in Chinese hamster ovary cells. J Nutr 1997;127(7):1304–10.
Hadley KB, Sunde RA. Selenium regulation of thioredoxin reductase activity and mRNA levels in rat liver. J Nutr Biochem 2001;12(12):693–702.
Chen J, Berry MJ. Selenium and selenoproteins in the brain and brain diseases. J Neurochem 2003;86(1):1–12.
Sun Y, Butler JA, Whanger PD. Glutathione peroxidase activity and selenoprotein W levels in different brain regions of selenium-depleted rats (1). J Nutr Biochem 2001;12(2):88–94.
Whanger PD. Selenium and the brain: a review. Nutr Neurosci 2001;4(2):81–97.
Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 2000;28(9):1405–20.
Berggren MM, Mangin JF, Gasdaka JR, Powis G. Effect of selenium on rat thioredoxin reductase activity: increase by supranutritional selenium and decrease by selenium deficiency. Biochem Pharmacol 1999;57(2):187–93.
Suchocki P, Misiewicz-Krzeminska I, Skupinska K, Niedzwiecka K, Lubelska K, Fijalek Z, et al. Selenitetriglicerydes affect CYP1A1 and QR activity by involvement of reactive oxygen species and Nrf2 transcription factor. Pharmacolo Rep 2010;62(2):352–61.
Mehlert A, Diplock AT. The glutathione S-transferases in selenium and vitamin E deficiency. Biochem J 1985;227(3):823–31.
El-Demerdash FM. Effects of selenium and mercury on the enzymatic activities and lipid peroxidation in brain, liver, and blood of rats. J Environ Sci Health B 2001;36(4):489–99.
Kaur P, Bansal MP. Effect of selenium-induced oxidative stress on the cell kinetics in testis and reproductive ability of male mice. Nutrition 2005;21(3):351–7.
Sanchez-Valle V, Chavez-Tapia NC, Uribe M, Mendez-Sanchez N. Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem 2012;19(28):4850–60.
Flis A, Suchocki P, Krolikowska MA, Suchocka Z, Remiszewska M, Sliwka L, et al. Selenitetriglycerides-redox-active agents. Pharmacol Rep 2015;67(1):1–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sochacka, M., Giebułtowicz, J., Remiszewska, M. et al. Effects of Selol 5% supplementation on tissue antioxidant enzyme levels and peroxidation marker in healthy mice. Pharmacol. Rep 70, 1073–1078 (2018). https://doi.org/10.1016/j.pharep.2018.06.003
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.pharep.2018.06.003